FDA seeks probe into communications between staff and Biogen over Alzheimer’s drug

BREAKING NEWS: FDA seeks probe into communications between its staff and Biogen after controversial approval of Alzheimer’s drug FDA commissioner Janet Woodcock has asked for a probe into her staff’s communications with Biogen Biogen’s Aduhelm received FDA approval for Alzhiemer’s disease in early June despite limited data that it worked in clinical trials   By Mansur Shaheen … Read more

FDA: Covid antibody tests CANNOT prove you are immune to virus from prior infection OR vaccination

Covid antibody tests CANNOT prove you are immune to the virus from prior infection OR vaccination, FDA warns The FDA warned Wednesday that relying on antibodies for protection from COVID-19 may leave people vulnerable A vaccine is still needed to confirm immunity from the effects of the virus Positive antibody tests also won’t work as … Read more

Covid US: FDA authorizes Pfizer vaccine for children aged 12-15

U.S. regulators gave Pfizer’s COVID-19 vaccine emergency use authorization for children ages 12 to 15, making it the first shot available to kids younger than 16, the Food and Drug Administration (FDA) announced Monday.   The shot was authorized for people ages 16 and up in December, and Pfizer has been in trials for teens since … Read more

FDA expected to authorize Pfizer’s Covid vaccine for teens ages 12-15 by next WEEK  

FDA expected to authorize Pfizer’s Covid vaccine for teens ages 12-15 by next WEEK   Food and Drug Administration is preparing to authorize Pfizer’s Covid vaccine for people ages 12-5, officials told the New York Times  Authorization is expected to come as early as late this week, or early next week  The Pfizer vaccine was authorized … Read more

FDA orders US plant to STOP making J&J’s Covid vaccine

FDA orders US plant to STOP making J&J’s Covid vaccine as it investigates ingredient mix-up that ruined 15 MILLION doses of the shot The FDA asked Emergent BioSolutions manufacturing plant in Baltimore to halt production of J&J’s vaccine on April 16  It comes after the plant accidentally used an ingredient intended for the AstraZeneca vaccine – … Read more

Covid: UK may approve one-dose Johnson & Johnson vaccine suspended by US FDA over blood clot fears

Covid vaccine blood clot fears have struck a second jab as the US today stopped using the Johnson & Johnson shot which the UK may approve within days. The Food and Drug Administration (FDA) has called for use of the jab to be suspended after six young women developed blood clots after receiving it. British … Read more

Covid-19: UK expecting 30m doses of Johnson & Johnson vaccine suspended by US FDA over blood clots

US regulators suspend use of Johnson & Johnson’s Covid vaccine over blood clot fears – with UK set to approve the single-dose jab ‘within days’ and start supply of 30million in summer UK expects deliveries in the second half of 2021, with approval likely this week Johnson & Johnson’s jab is the only one-dose vaccine … Read more

FDA and CDC are set to call for Johnson & Johnson COVID vaccine to be paused

FDA and CDC call for Johnson & Johnson COVID vaccine to be PAUSED after six women out of nearly seven million people developed rare blood clots The FDA and CDC have called for Johnson & Johnson’s single-dose vaccine to be stopped in the U.S Seven million people in the U.S. have recieved the Johnson & … Read more

FDA and CDC are set to call for Johnson & Johnson COVID vaccine to be paused

FDA and CDC call for Johnson & Johnson COVID vaccine to be PAUSED after six women out of nearly seven million people developed rare blood clots Seven million people in the U.S. have recieved the Johnson & Johnson vaccine  By Dailymail.com Reporter Published: 11:59 BST, 13 April 2021 | Updated: 12:15 BST, 13 April 2021 … Read more

Regeneron to ask FDA to use its COVID-19 antibody drug as a preventative treatment

Regeneron Pharmaceuticals plans to ask the U.S. Food and Drug Administration (FDA) to allow its COVID-19 monoclonal antibody cocktail to be used as a preventative treatment.  It comes after data from a Phase III clinical trial, run together with the National Institutes of Health, found the drug reduced the risk of asymptomatic coronavirus  patients developing symptoms … Read more